[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid

C46H54B2Cl2N8O5S — CID 157222023

IUPAC[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid
SMILESCB(O)N1CCN(C2c3ccc(Cl)cc3C(COS(C)(=O)=O)=Cc3cccnc32)CC1.CCc1nccn1CC1=Cc2cccnc2C(N2CCN(B(C)O)CC2)c2ccc(Cl)cc21
InChIInChI=1S/C25H29BClN5O.C21H25BClN3O4S/c1-3-23-28-9-10-31(23)17-19-15-18-5-4-8-29-24(18)25(21-7-6-20(27)16-22(19)21)30-11-13-32(14-12-30)26(2)33;1-22(27)26-10-8-25(9-11-26)21-18-6-5-17(23)13-19(18)16(14-30-31(2,28)29)12-15-4-3-7-24-20(15)21/h4-10,15-16,25,33H,3,11-14,17H2,1-2H3;3-7,12-13,21,27H,8-11,14H2,1-2H3
InChIKeyATCJXFZSLRSCLQ-UHFFFAOYSA-N
MW923.59 g/mol
LogP6.25
Rot. Bonds10

About [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid

[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid (PubChem CID 157222023) has the molecular formula C46H54B2Cl2N8O5S and a molecular weight of 923.59 g/mol. Its IUPAC name is [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid.

Molecular Properties

Compound Name[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid
PubChem CID157222023
Molecular FormulaC46H54B2Cl2N8O5S
Molecular Weight923.59 g/mol
Exact Mass922.35
IUPAC Name[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid
SMILESCB(O)N1CCN(C2c3ccc(Cl)cc3C(COS(C)(=O)=O)=Cc3cccnc32)CC1.CCc1nccn1CC1=Cc2cccnc2C(N2CCN(B(C)O)CC2)c2ccc(Cl)cc21
InChIInChI=1S/C25H29BClN5O.C21H25BClN3O4S/c1-3-23-28-9-10-31(23)17-19-15-18-5-4-8-29-24(18)25(21-7-6-20(27)16-22(19)21)30-11-13-32(14-12-30)26(2)33;1-22(27)26-10-8-25(9-11-26)21-18-6-5-17(23)13-19(18)16(14-30-31(2,28)29)12-15-4-3-7-24-20(15)21/h4-10,15-16,25,33H,3,11-14,17H2,1-2H3;3-7,12-13,21,27H,8-11,14H2,1-2H3
InChIKeyATCJXFZSLRSCLQ-UHFFFAOYSA-N
XLogP6.25
TPSA140.39 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms64
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500923.59
LogP ≤ 56.25
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}

Analyze [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid?
The IUPAC name of [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid (CID 157222023) is [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid.
What is the SMILES notation for [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid?
The canonical SMILES for [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid is CB(O)N1CCN(C2c3ccc(Cl)cc3C(COS(C)(=O)=O)=Cc3cccnc32)CC1.CCc1nccn1CC1=Cc2cccnc2C(N2CCN(B(C)O)CC2)c2ccc(Cl)cc21.
What is the InChIKey of [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid?
The InChIKey is ATCJXFZSLRSCLQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29BClN5O.C21H25BClN3O4S/c1-3-23-28-9-10-31(23)17-19-15-18-5-4-8-29-24(18)25(21-7-6-20(27)16-22(19)21)30-11-13-32(14-12-30)26(2)33;1-22(27)26-10-8-25(9-11-26)21-18-6-5-17(23)13-19(18)16(14-30-31(2,28)29)12-15-4-3-7-24-20(15)21/h4-10,15-16,25,33H,3,11-14,17H2,1-2H3;3-7,12-13,21,27H,8-11,14H2,1-2H3.
What are the key properties of [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid?
[4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid has a molecular weight of 923.59 g/mol, XLogP of 6.25, 10 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[13-chloro-10-[(2-ethylimidazol-1-yl)methyl]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid;[4-[13-chloro-10-(methylsulfonyloxymethyl)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl]piperazin-1-yl]-methylborinic acid is sourced from PubChem (CID 157222023), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).